OTCMKTS:RDGL Vivos (RDGL) Stock Forecast, Price & News $0.05 0.00 (0.00%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$0.05▼$0.0650-Day Range$0.05▼$0.1152-Week Range$0.04▼$0.12Volume333,556 shsAverage Volume599,620 shsMarket Capitalization$20.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest About Vivos (OTCMKTS:RDGL) StockVivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. The firm's product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Richland, WA.Read More Receive RDGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivos and its competitors with MarketBeat's FREE daily newsletter. Email Address RDGL Stock News HeadlinesMay 15, 2023 | finance.yahoo.comVivos Inc. (RDGL) Stock Historical Prices & Data - Yahoo FinanceJanuary 11, 2023 | finance.yahoo.comVivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide TherapyJune 9, 2023 | Vantage Point (Ad)America's Worst Nightmare: A Major Financial Crisis LoomsSomething strange is happening in our financial system. UBS analysts predict over 50,000 retail locations may close soon. Retail giants like Walmart, Foot Locker, Bed Bath & Beyond, and Macy's are already downsizing their stores. Are you using the best technology to protect your money at all costs? January 5, 2023 | reuters.comRDGL.PK - Vivos Inc | Stock Price & Latest News | ReutersJanuary 3, 2023 | finance.yahoo.comVivos Inc Files a New Patent on Precision Radionuclide Therapy Support System EquipmentSeptember 15, 2022 | stockhouse.comVivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel(TM)September 14, 2022 | finance.yahoo.comVivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™August 18, 2022 | nz.finance.yahoo.comDua Lipa's LBD Looked Like a Pair of Pants With StrapsJune 9, 2023 | Vector Vest (Ad)Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. August 16, 2022 | uk.investing.comGreat Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively BuyingAugust 16, 2022 | finance.yahoo.comVivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine TherapyJuly 15, 2022 | benzinga.comVivos (OTC:RDGL), Analyst Ratings, Price Targets, PredictionsJuly 14, 2022 | benzinga.comVivos (OTC:RDGL), Earnings Estimates, EPS, and RevenueMay 12, 2022 | finance.yahoo.comVivos Inc. Provides Intellectual Property Protection UpdateApril 21, 2022 | apnews.comVivos Inc Implements Multiple Patient IsoPet® Therapy DayFebruary 24, 2022 | finance.yahoo.comVivos Inc. Enhances its Intellectual Property ProtectionJanuary 21, 2022 | nasdaq.comRDGL Real-Time QuotesDecember 2, 2021 | stockhouse.comVivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel(TM)December 2, 2021 | finance.yahoo.comVivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel™November 23, 2021 | finance.yahoo.comVivos Inc Announces Johns Hopkins University (Veterinary Clinical Trials Network) is a New Regional Clinic for Isopet®November 22, 2021 | finance.yahoo.comVivos Inc Announces John Hopkins University as a New Regional Clinic for Isopet®September 20, 2021 | stockhouse.comVivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel(TM)September 20, 2021 | finance.yahoo.comVivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™June 24, 2021 | finance.yahoo.comVivos Inc Initiates Isopet® Therapy in HorsesMay 27, 2021 | finance.yahoo.comVivos Inc. Expands IsoPet® Trademark ProtectionMay 26, 2021 | ca.finance.yahoo.comApple Rush Company, Inc. partner, Botanaway, Inc. featured in May 16th article in Cannabis Now magazineMay 26, 2021 | yahoo.comI & J / Whitefield Consortium to Lead EXOS Aerospace Series A RaiseSee More Headlines RDGL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDGL Company Calendar Today6/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorFinance Current SymbolOTCMKTS:RDGL CUSIPN/A CIK1449349 Webwww.radiogel.com Phone(509) 736-4000Fax509-736-4007Employees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,470,000.00 Net Margins-6,616.61% Pretax Margin-6,616.61% Return on EquityN/A Return on Assets-126.94% Debt Debt-to-Equity RatioN/A Current Ratio29.84 Quick Ratio29.84 Sales & Book Value Annual Sales$40,000.00 Price / Sales506.05 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-2.74Miscellaneous Outstanding Shares369,380,000Free Float301,044,000Market Cap$20.24 million OptionableNot Optionable Beta1.68 Key ExecutivesCarlton M. CadwellChairman & SecretaryMichael K. KorenkoPresident, Chief Executive Officer & DirectorMichael H. PollackChief Financial OfficerNigel Raymond StevensonChief Science OfficerDavid J. SwanbergChief Technical ManagerKey CompetitorsSVB Financial GroupNASDAQ:SIVBiPath Bloomberg Cocoa Subindex Total Return ETNNYSEARCA:NIBSVB Financial GroupNASDAQ:SIVBQMicroSectors U.S. Big Oil Index Inverse ETNsNYSEARCA:YGRNGreen Planet BioengineeringOTCMKTS:GPLBView All Competitors RDGL Stock - Frequently Asked Questions How have RDGL shares performed in 2023? Vivos' stock was trading at $0.0444 at the beginning of the year. Since then, RDGL stock has increased by 23.4% and is now trading at $0.0548. View the best growth stocks for 2023 here. Are investors shorting Vivos? Vivos saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 47,300 shares, a decline of 25.5% from the April 30th total of 63,500 shares. Based on an average daily volume of 2,153,000 shares, the days-to-cover ratio is presently 0.0 days. View Vivos' Short Interest. What is Vivos' stock symbol? Vivos trades on the OTCMKTS under the ticker symbol "RDGL." How do I buy shares of Vivos? Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Vivos' stock price today? One share of RDGL stock can currently be purchased for approximately $0.05. How much money does Vivos make? Vivos (OTCMKTS:RDGL) has a market capitalization of $20.24 million and generates $40,000.00 in revenue each year. How can I contact Vivos? Vivos' mailing address is 719 JADWIN AVENUE, RICHLAND WA, 99352. The official website for the company is www.radiogel.com. The company can be reached via phone at (509) 736-4000 or via fax at 509-736-4007. This page (OTCMKTS:RDGL) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.